Semax (10mg) is a research-grade peptide being studied in various preclinical and experimental studies for its potential nootropic, neurological, and neuroprotective properties. The peptide is a modified heptapeptide based on the natural tetrapeptide ACTH(4-10), developed to improve stability and efficacy.
In scientific research, Semax is being investigated for its potential effects on attention, memory, mood, stress regulation, and neurochemical processes.
Research findings
In several preclinical studies it was observed that Semax:
influences neurotransmitters such as dopamine, serotonin and GABA
can induce an increase in BDNF expression, an important factor for learning, recovery and neuroplasticity
can improve cognitive performance (focus, memory, information processing) in animal models
possibly reduces stress and anxiety-related markers
plays a role in neurological protection, such as improving oxidative stress parameters and inflammatory markers
These findings have been observed exclusively in laboratory and preclinical settings. Semax is not approved for human or therapeutic use.
Research context
Semax is used in laboratories and research institutions to:
the effects on cognitive functions such as attention, memory and learning ability
the role in neuroplasticity and BDNF regulation
possible interactions with stress and anxiety regulation
to analyze the influence on neurological, immune and inflammatory processes .
The peptide is used exclusively for in vitro research, reference standards, and preclinical research purposes.
Not developed or approved for medical, cosmetic or therapeutic use.
Important information
For laboratory research only
Not intended for human consumption or injection.
For research and development purposes only.
Buyer is responsible for compliance with local laws and regulations.
The seller is not liable for incorrect or improper use.
Sale
Sale
